SCHEMBL574028

SCHEMBL574028

CCCCNc1cc(C(=O)OC)cc(S(=O)(=O)N=CN(C)C)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 5/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ LMNA P02545 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ BLM P54132 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ SLC12A2 P55011 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CISD1 Q9NZ45 7/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574027 1.00 MAPT (0.40) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL574330 0.86 LMNA (0.39) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL574329 0.86 LMNA (0.39) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL572925 0.82 KDM4E (0.59) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL10222976 0.82 KDM4E (0.59) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL572924 0.82 KDM4E (0.59) KDM4EALDH1A1LMNAHPGDTSHR
SCHEMBL21436403 0.81 KDM4E (0.35) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL21436385 0.81 KDM4E (0.35) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL21436389 0.81 KDM4E (0.35) MAPTKDM4EALDH1A1LMNAHPGD
SCHEMBL21436661 0.81 CA2 (0.41) MAPTKDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback